View in EDS HTML Full Text PDF Full Text

Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.

Saved in:
Bibliographic Details
Title: Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.
Authors: Ferguson, Robert J. (AUTHOR), McDonald, Brenna C. (AUTHOR), Rocque, Michael A. (AUTHOR), Furstenberg, Charlotte T. (AUTHOR), Horrigan, Susan (AUTHOR), Ahles, Tim A. (AUTHOR), Saykin, Andrew J. (AUTHOR)
Source: Psycho-Oncology. Feb2012, Vol. 21 Issue 2, p176-186. 11p.
Subjects: Cognitive therapy, Cognition disorders treatment, Breast cancer chemotherapy, Memory, Quality of life, Clinical trials
Abstract: Objective: To evaluate the efficacy of a brief cognitive-behavioral therapy (CBT) that is being developed for management of cognitive dysfunction following chemotherapy among breast cancer survivors. Memory and Attention Adaptation Training (MAAT) is a brief CBT designed to improve the quality of life and function among cancer survivors with post-chemotherapy cognitive complaints. Methods: An initial, two-group (MAAT versus waitlist, no treatment control), randomized clinical trial (RCT) was conducted. Forty stage I and II female breast cancer survivors (mean age = 50; SD = 6.4) were randomized to conditions and assessed at baseline, post-treatment (8 weeks) and 2-month follow-up assessment points on measures of: (1) self-reported daily cognitive failures; (2) quality of life; and (3) neuropsychological performance. Participants were also assessed for satisfaction with MAAT. Results: With education and IQ as covariates, MAAT participants made significant improvements relative to controls on the spiritual well-being subscale of the quality of life measure and on verbal memory, but statistical significance was not achieved on self-report of daily cognitive complaints. However, moderate-to-large effect sizes were observed on these outcomes. Participants gave MAAT high satisfaction ratings. Conclusions: Although this initial RCT is a small study, MAAT participants appear to improve on one measure of quality of life and verbal memory performance relative to no treatment controls and rate MAAT with high satisfaction. These data are encouraging and support the continued development and evaluation of MAAT efficacy.Copyright © 2010 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 70602431
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ferguson%2C+Robert+J%2E%22">Ferguson, Robert J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McDonald%2C+Brenna+C%2E%22">McDonald, Brenna C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rocque%2C+Michael+A%2E%22">Rocque, Michael A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Furstenberg%2C+Charlotte+T%2E%22">Furstenberg, Charlotte T.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Horrigan%2C+Susan%22">Horrigan, Susan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahles%2C+Tim+A%2E%22">Ahles, Tim A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saykin%2C+Andrew+J%2E%22">Saykin, Andrew J.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psycho-Oncology%22">Psycho-Oncology</searchLink>. Feb2012, Vol. 21 Issue 2, p176-186. 11p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Cognitive+therapy%22">Cognitive therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Cognition+disorders+treatment%22">Cognition disorders treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Breast+cancer+chemotherapy%22">Breast cancer chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Memory%22">Memory</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+life%22">Quality of life</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: To evaluate the efficacy of a brief cognitive-behavioral therapy (CBT) that is being developed for management of cognitive dysfunction following chemotherapy among breast cancer survivors. Memory and Attention Adaptation Training (MAAT) is a brief CBT designed to improve the quality of life and function among cancer survivors with post-chemotherapy cognitive complaints. Methods: An initial, two-group (MAAT versus waitlist, no treatment control), randomized clinical trial (RCT) was conducted. Forty stage I and II female breast cancer survivors (mean age = 50; SD = 6.4) were randomized to conditions and assessed at baseline, post-treatment (8 weeks) and 2-month follow-up assessment points on measures of: (1) self-reported daily cognitive failures; (2) quality of life; and (3) neuropsychological performance. Participants were also assessed for satisfaction with MAAT. Results: With education and IQ as covariates, MAAT participants made significant improvements relative to controls on the spiritual well-being subscale of the quality of life measure and on verbal memory, but statistical significance was not achieved on self-report of daily cognitive complaints. However, moderate-to-large effect sizes were observed on these outcomes. Participants gave MAAT high satisfaction ratings. Conclusions: Although this initial RCT is a small study, MAAT participants appear to improve on one measure of quality of life and verbal memory performance relative to no treatment controls and rate MAAT with high satisfaction. These data are encouraging and support the continued development and evaluation of MAAT efficacy.Copyright © 2010 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=70602431
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pon.1878
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 176
    Subjects:
      – SubjectFull: Cognitive therapy
        Type: general
      – SubjectFull: Cognition disorders treatment
        Type: general
      – SubjectFull: Breast cancer chemotherapy
        Type: general
      – SubjectFull: Memory
        Type: general
      – SubjectFull: Quality of life
        Type: general
      – SubjectFull: Clinical trials
        Type: general
    Titles:
      – TitleFull: Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferguson, Robert J.
      – PersonEntity:
          Name:
            NameFull: McDonald, Brenna C.
      – PersonEntity:
          Name:
            NameFull: Rocque, Michael A.
      – PersonEntity:
          Name:
            NameFull: Furstenberg, Charlotte T.
      – PersonEntity:
          Name:
            NameFull: Horrigan, Susan
      – PersonEntity:
          Name:
            NameFull: Ahles, Tim A.
      – PersonEntity:
          Name:
            NameFull: Saykin, Andrew J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 10579249
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Psycho-Oncology
              Type: main
ResultId 1